feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Silent Disaster: India Battles Superbug Threat

Silent Disaster: India Battles Superbug Threat

13 Jan

•

Summary

  • AMR is a silent disaster threatening humanity, making infections untreatable.
  • Incomplete antibiotic courses and misuse are primary drivers of AMR.
  • Gujarat's new BSL-4 facility bolsters India's biosafety and research capabilities.
Silent Disaster: India Battles Superbug Threat

Antimicrobial Resistance (AMR), described as a silent disaster, is a growing global threat where medicines become ineffective against bacteria, viruses, fungi, and parasites. This resistance makes common infections difficult or impossible to treat, escalating the risks of severe illness and death. The misuse of antibiotics, including incomplete treatment courses and self-medication, significantly contributes to AMR's spread.

Recognizing the urgency, India is bolstering its biosafety infrastructure. Gujarat has inaugurated India's second BSL-4 Biocontainment Facility, a high-tech laboratory designed for researching highly contagious viruses in a secure environment. This ₹362 crore facility is the first of its kind established by a state government, marking a significant advancement in national biosafety efforts.

trending

Blinkit ends 10-minute delivery

trending

IBM expands edge AI

trending

TNSTC operates festival special buses

trending

Afghan student found dead at MSU

trending

KNRUHS scraps maternity fee

trending

SBI Clerk Mains Result Soon

trending

Kaka launches women's safety app

trending

Punjab sets 346-run target

trending

Tata Punch facelift launched

The new BSL-4 lab aims to foster crucial research and development in virology, providing a platform for young scientists. Its establishment is part of a broader strategy to enhance medicine literacy, promote research, and educate the public about the dangers of AMR, safeguarding antibiotics for future generations.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The BSL-4 facility in Gujarat is India's second-highest biosafety lab, built for researching dangerous viruses and contagious microorganisms.
AMR occurs when microbes stop responding to medicines, making infections untreatable and posing a significant risk to public health.
India is increasing medicine literacy, investing in research, and establishing advanced biosafety facilities like the new BSL-4 lab in Gujarat.

Read more news on

Healthside-arrowGujaratside-arrow

You may also like

Superbugs Threaten Sight After Cataract Surgery

8 Jan • 39 reads

article image

Ahmedabad Chills: Winter's Coldest Night Recorded

10 Jan • 18 reads

article image

Superbug Threat Detected Early in Hospital Drains

23 Dec, 2025 • 80 reads

article image

E. coli found; Scottish Water piped contaminated water for a year

21 Dec, 2025 • 98 reads

article image

AMR Crisis Worsens: Essential Antibiotics Losing Power

11 Dec, 2025 • 138 reads